Protective activity of Streptococcus pneumoniae spr1875 protein fragments identified using a phage displayed genomic library

PLoS ONE

Volumn 7, Issue 5, 2012, Pages

  Cardaci, Angela ^a   Papasergi, Salvatore ^a   Midiri, Angelina ^a   Mancuso, Giuseppe ^a   Domina, Maria ^a   Cariccio, Veronica Lanza ^a   Mandanici, Francesca ^a   Galbo, Roberta ^a   Lo Passo, Carla ^a   Pernice, Ida ^a   Donato, Paolo ^b   Ricci, Susanna ^c   Biondo, Carmelo ^a   Teti, Giuseppe ^a   Felici, Franco ^d   Beninati, Concetta ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b NOVARTIS VACCINES AND DIAGNOSTICS   (Italy)

^c UNIVERSITY OF SIENA   (Italy)

^d UNIVERSITY OF MOLISE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL ANTIGEN; BACTERIAL PROTEIN; EPITOPE; SPR1875 PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; BACTERIAL STRAIN; BACTERIAL VIRULENCE; BACTERIOPHAGE; CONTROLLED STUDY; GENE LIBRARY; IMMUNITY; IMMUNIZATION; IMMUNOFLUORESCENCE; NONHUMAN; NUCLEOTIDE SEQUENCE; OPEN READING FRAME; PHAGE DISPLAY; PROTEIN ANALYSIS; SEPSIS; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; WILD TYPE;

MUS; STREPTOCOCCUS PNEUMONIAE;

EID: 84860528401     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0036588     Document Type: Article

References (25)

1. Rehm SJ, Farley MM, File TM Jr, Hall WJ, Hopkins R, et al. (2009) Higher pneumococcal disease vaccination rates needed to protect more at-risk US adults. Postgrad Med 121: 101-105.
2. File TM, (2003) Community-acquired pneumonia. Lancet 362: 1991-2001.
3. Hicks LA, Harrison LH, Flannery B, Hadler JL, Schaffner W, et al. (2007) Incidence of pneumococcal disease due to non-pneumococcal conjugate vaccine (PCV7) serotypes in the United States during the era of widespread PCV7 vaccination, 1998-2004. J Infect Dis 196: 1346-1354.
4. Miller E, Andrews NJ, Waight PA, Slack MP, George RC, (2011) Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infect Dis 11: 760-8.
5. Bogaert D, Hermans PW, Adrian PV, Rümke HC, de Groot R, (2004) Pneumococcal vaccines: an update on current strategies. Vaccine 22: 2209-2220.
6. Beghetto E, Gargano N, Ricci S, Garufi G, Peppoloni S, et al. (2006) Discovery of novel Streptococcus pneumoniae antigens by screening a whole-genome λ display library. FEMS Microbiol Lett 206: 14-21.
7. Papasergi S, Garibaldi M, Tuscano G, Signorino G, Ricci S, (2010) Plasminogen- and fibronectin-binding protein B is involved in the adherence of Streptococcus pneumoniae to human epithelial cells. J Biol Chem 285: 7517-7524.
8. Tu AH, Fulgham RL, McCrory MA, Briles DE, Szalai AJ, (1999) Pneumococcal surface protein A inhibits complement activation by Streptococcus pneumoniae. Infect Immun 67: 4720-4724.
9. Ng WL, Tsui HC, Winkler ME, (2005) Regulation of the pspA virulence factor and essential pcsB murein biosynthetic genes by the phosphorylated VicR (YycF) response regulator in Streptococcus pneumoniae. J Bacteriol 187: 7444-7459.
10. Buist G, Steen A, Kok J, Kuipers OP, (2008) LysM, a widely distributed protein motif for binding to (peptido)glycans. Mol Microbiol 68: 838-847.
11. Downer R, Roche F, Park PW, Mecham RP, Foster TJ, (2002) The elastin-binding protein of Staphylococcus aureus (EbpS) is expressed at the cell surface as an integral membrane protein and not as a cell wall-associated protein. J Biol Chem 277: 243-250.
12. Maione D, Margarit I, Rinaudo CD, Masignani V, Mora M, et al. (2005) Identification of a universal Group B streptococcus vaccine by multiple genome screen. Science 309: 148-150.
13. Martin D, Rioux S, Gagnon E, Boyer M, Hamel J, et al. (2002) Protection from group B streptococcal infection in neonatal mice by maternal immunization with recombinant Sip protein. Infect Immun 70: 4897-4901.
14. Bootsma HJ, Egmont-Petersen M, Hermans PW, (2007) Analysis of the in vitro transcriptional response of human pharyngeal epithelial cells to adherent Streptococcus pneumoniae: evidence for a distinct response to encapsulated strains. Infect Immun 75: 5489-4599.
15. Hammerschmidt S, (2006) Adherence molecules of pathogenic pneumococci. Curr Opin Microbiol 9: 12-20.
16. Stålhammar-Carlemalm M, Waldemarsson J, Johnsson E, Areschoug T, Lindahl G, (2007) Nonimmunodominant regions are effective as building blocks in a streptococcal fusion protein vaccine. Cell Host Microbe 2: 427-434.
17. Lannergård J, Gustafsson MC, Waldemarsson J, Norrby-Teglund A, Stålhammar-Carlemalm M, et al. (2011) The Hypervariable Region of Streptococcus pyogenes M Protein Escapes Antibody Attack by Antigenic Variation and Weak Immunogenicity. Cell Host Microbe 10: 147-157.
18. Waldemarsson J, Stålhammar-Carlemalm M, Sandin C, Castellino FJ, Lindahl G, (2009) Functional dissection of Streptococcus pyogenes M5 protein: the hypervariable region is essential for virulence. PLoS One 4: e7279.
19. Iannelli F, Pearce BJ, Pozzi G, (1999) The type 2 capsule locus of Streptococcus pneumoniae. J Bacteriol 181: 2652-2654.
20. Hoskins J, Alborn WE Jr, Arnold J, Blaszczak LC, Burgett S, et al. (2001) Genome of the bacterium Streptococcus pneumoniae R6. J Bacteriol 183: 5709-5717.
21. Horton RM, Cai Z, Ho SN, Pease LN, (1990) Gene splicing by overlap extension: tailor-made genes using the polymerase chain reaction. BioTechniques 8: 528-532.
22. Oggioni MR, Memmi G, Maggi T, Chiavolini D, Iannelli F, et al. (2003) Pneumococcal zinc metalloproteinase ZmpC cleaves human matrix metalloproteinase 9 and is a virulence factor in experimental pneumonia. Mol Microbiol 49: 795-805.
23. Pearce BJ, Iannelli F, Pozzi G, (2002) Construction of new unencapsulated (rough) strains of Streptococcus pneumoniae. Res Microbiol 153: 243-7.
24. Beghetto E, Spadoni A, Buffolano W, Del Pezzo M, Minenkova O, et al. (2003) Molecular dissection of Human B cell response against Toxoplasma gondii infection by lambda display of cDNA libraries. Int J Parassitol 33: 163-173.
25. Garibaldi M, Rodríguez-Ortega MJ, Mandanici F, Cardaci A, Midiri A, et al. (2010) 28: 3609-16 Vaccine. Immunoprotective activities of a Streptococcus suis pilus subunit in murine models of infection.